论文部分内容阅读
目的分析依降钙素联合利塞膦酸钠对绝经后骨质疏松患者慢性腰背痛缓解及生活质量改善的作用。方法研究开展于2016年1—10月,选取该院收治的60例绝经后骨质疏松患者,随机将其分为B组(n=30)与A组(n=30),B组单纯使用利塞膦酸钠治疗,A组应用利塞膦酸钠+依降钙素治疗,对比两组患者的治疗后主观疼痛程度与生活质量。结果在治疗后6个月后,两组患者骨质疏松疼痛均有所缓解,A组疼痛改善程度明显优于B组,组间比较差异有统计学意义(P<0.05);对比两组患者治疗后生活质量改善情况,A组与B组差异有统计学意义(P<0.05)。结论对绝经后骨质疏松患者采用降钙素增强双膦酸盐治疗,可有效缓解患者慢性腰背酸痛体征,提高患者的生活质量,适合临床应用与推广。
Objective To analyze the effect of Eca-Catechine and risedronate on relieving chronic low back pain and improving quality of life in postmenopausal osteoporosis patients. METHODS: From January to October 2016, 60 patients with postmenopausal osteoporosis who were admitted to our hospital were randomly divided into group B (n = 30) and group A (n = 30), group B Risedronate sodium treatment, A group of application of risedronate sodium + e calcitonin treatment, the two groups of patients after treatment subjective pain and quality of life. Results After 6 months of treatment, the pain of osteoporosis was relieved in both groups. The improvement of pain in group A was better than that in group B, the difference was statistically significant (P <0.05) After treatment, the improvement of quality of life, A group and B group difference was statistically significant (P <0.05). Conclusions The use of calcitonin to enhance bisphosphonates in postmenopausal osteoporosis patients can effectively alleviate the signs of chronic back pain in patients and improve the quality of life of patients and is suitable for clinical application and promotion.